Invention Grant
- Patent Title: 3-methylideneoxan-4-one compounds and substituted derivatives thereof as inhibitors of telomerase
-
Application No.: US16986718Application Date: 2020-08-06
-
Publication No.: US11518750B2Publication Date: 2022-12-06
- Inventor: Karl A. Scheidt , Rick C. Betori
- Applicant: NORTHWESTERN UNIVERSITY
- Applicant Address: US IL Evanston
- Assignee: NORTHWESTERN UNIVERSITY
- Current Assignee: NORTHWESTERN UNIVERSITY
- Current Assignee Address: US IL Evanston
- Agency: Quarles & Brady LLP
- Main IPC: C07D309/32
- IPC: C07D309/32 ; C07D405/06
Abstract:
Disclosed are 3-methylideneoxan-4-one compounds, derivatives thereof, and methods of their synthesis and methods of their use in treating a disease or disorder in a subject in need thereof, such as diseases and disorders that are associated with telomerase activity such as cancer. The disclosed compounds may be formulated in a pharmaceutical composition for treating diseases and disorders that are associated with telomerase activity such as cancer.
Public/Granted literature
- US20210070725A1 3-METHYLIDENEOXAN-4-ONE COMPOUNDS AND SUBSTITUTED DERIVATIVES THEREOF AS INHIBITORS OF TELOMERASE Public/Granted day:2021-03-11
Information query
